ES2033871T3 - Un procedimiento para producir una preparacion de insulina para administracion parenteral. - Google Patents

Un procedimiento para producir una preparacion de insulina para administracion parenteral.

Info

Publication number
ES2033871T3
ES2033871T3 ES198787309229T ES87309229T ES2033871T3 ES 2033871 T3 ES2033871 T3 ES 2033871T3 ES 198787309229 T ES198787309229 T ES 198787309229T ES 87309229 T ES87309229 T ES 87309229T ES 2033871 T3 ES2033871 T3 ES 2033871T3
Authority
ES
Spain
Prior art keywords
parenteral administration
procedure
producing
insulin preparation
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787309229T
Other languages
English (en)
Inventor
Klavs Holger Joergensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2033871T3 publication Critical patent/ES2033871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

PREPARACIONES DE INSULINA CON PROPIEDADES MEJORADAS PARA ADMINISTRACION PARENTERAL SE PUEDEN PREPARAR A VALORES DE PH 3 A 8,5 APROXIMADAMENTE, EN PRESENCIA DE IONES DE MAGNESIO EN CONCENTRACION DE 0,005 A 0,05 M APROXIOMADAMENTE.
ES198787309229T 1986-10-20 1987-10-19 Un procedimiento para producir una preparacion de insulina para administracion parenteral. Expired - Lifetime ES2033871T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK356987A DK356987D0 (es) 1987-07-10 1987-07-10

Publications (1)

Publication Number Publication Date
ES2033871T3 true ES2033871T3 (es) 1993-04-01

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787309229T Expired - Lifetime ES2033871T3 (es) 1986-10-20 1987-10-19 Un procedimiento para producir una preparacion de insulina para administracion parenteral.

Country Status (18)

Country Link
US (1) US5070186A (es)
EP (1) EP0265213B1 (es)
KR (1) KR880004819A (es)
CN (1) CN87107049A (es)
AU (1) AU616381B2 (es)
CA (1) CA1316819C (es)
DE (1) DE3778287D1 (es)
ES (1) ES2033871T3 (es)
FI (1) FI86254C (es)
GR (1) GR3004912T3 (es)
HU (1) HU201475B (es)
IE (1) IE60264B1 (es)
IL (1) IL84203A (es)
NO (1) NO170754C (es)
NZ (1) NZ222214A (es)
PH (1) PH23446A (es)
PT (1) PT85949B (es)
YU (1) YU46665B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
AU1870099A (en) * 1998-01-09 1999-07-26 Novo Nordisk A/S Stabilised insulin compositions
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
RU2318492C2 (ru) * 2001-08-27 2008-03-10 Ново Нордиск А/С Баллончик и система подачи лекарственного препарата, включающая в себя такой баллончик
AU2003300126B2 (en) * 2002-12-31 2010-04-01 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
CA2512052C (en) * 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
CN101573133B (zh) 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
EP2074141B1 (en) 2006-09-22 2016-08-10 Novo Nordisk A/S Protease resistant insulin analogues
CN101674812B (zh) 2007-04-30 2013-12-11 诺沃-诺迪斯克有限公司 干燥蛋白组合物的方法、干燥的蛋白组合物和包含干燥的蛋白的药物组合物
WO2008132229A2 (en) * 2007-04-30 2008-11-06 Novo Nordisk A/S Highly concentrated insulin solutions and compositions
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー/エス プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
RS56632B1 (sr) 2008-10-17 2018-03-30 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN103917241A (zh) 2011-08-29 2014-07-09 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US9481721B2 (en) 2012-04-11 2016-11-01 Novo Nordisk A/S Insulin formulations
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
MX369511B (es) 2013-04-03 2019-11-11 Sanofi Sa Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de acción prolongada.
HUE036702T2 (hu) 2013-10-07 2018-07-30 Novo Nordisk As Inzulinanalóg új származéka
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン/リキシセナチド固定比処方
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN115154591B (zh) 2016-12-16 2023-04-14 诺和诺德股份有限公司 含胰岛素的药物组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
AU616381B2 (en) 1991-10-31
EP0265213A2 (en) 1988-04-27
HU201475B (en) 1990-11-28
NO170754B (no) 1992-08-24
NO874347L (no) 1988-04-21
FI86254B (fi) 1992-04-30
CN87107049A (zh) 1988-07-06
GR3004912T3 (es) 1993-04-28
AU7990787A (en) 1988-04-21
IE872799L (en) 1988-04-20
CA1316819C (en) 1993-04-27
NZ222214A (en) 1989-11-28
NO874347D0 (no) 1987-10-19
PT85949B (pt) 1990-07-31
IL84203A (en) 1993-04-04
HUT46232A (en) 1988-10-28
EP0265213B1 (en) 1992-04-15
FI874596A0 (fi) 1987-10-19
KR880004819A (ko) 1988-06-27
FI86254C (fi) 1992-08-10
YU46665B (sh) 1994-01-20
FI874596A (fi) 1988-04-21
YU191887A (en) 1989-04-30
PT85949A (en) 1987-11-01
DE3778287D1 (de) 1992-05-21
PH23446A (en) 1989-08-07
IE60264B1 (en) 1994-06-29
NO170754C (no) 1992-12-02
EP0265213A3 (en) 1988-11-09
US5070186A (en) 1991-12-03

Similar Documents

Publication Publication Date Title
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
ES2007607A6 (es) Un procedimiento para la obtencion de un preparado de insulina para la administracion no parenteral.
ES8403025A1 (es) Procedimiento para preparar una solucion de insulina estabilizada.
SE8402560L (sv) Farmaceutisk komposition
ES8707195A1 (es) Procedimiento para preparar fenotoina en solucion
ATE64526T1 (de) Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion.
ES458710A1 (es) Un metodo para la obtencion de un preparado de cefalexina deaccion prolongada.
JPS5244222A (en) Method of making insulin preparations for rectal application
EP1283044A3 (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
KR840001279A (ko) 항종양 물질의 제조방법
EP0132359A3 (en) Natural human interleukin-2 and production thereof
DK499583D0 (da) Fremgangsmade til fremstilling af en isoquinolinforbindelse
ES8601694A1 (es) Procedimiento para preparar un compuesto de inclusion a base de n,n-dimetil-2-cloro-5(3-metil-2-(fenilimino)-4-tiazolin-4-il)-fenilsulfonamida y b-ciclodextrina
IT8783642A0 (it) Procedimento di fabbricazione di macchinette per incidere e rompere, nettamente, le piastrelle in ceramica, durissima, omogenea e macchinette ottenute con tale procedimento.
JPS539312A (en) Preparation of light-stable mecobalamin or cobamamide parenteral injections
DK540087A (da) Peptidpraeparat
JPS5417182A (en) Preparation of choline-oxidase
JPS5372894A (en) Preparation of l-serine by fermentation
JPS51123902A (en) Plunger pump
JPS5423194A (en) Preparation of inosine-5'-monophosphate
GB1254948A (en) Antivirial substance
JPS5231834A (en) Anti-coccidium agents
UA25289C2 (uk) Спосіб приготування горілки "імператорська"
ES8707512A1 (es) Procedimiento para preparar 6-etoxi-4-metil-benzotiazol-2 (3h)-ona
JPS5238032A (en) Coccidicides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 265213

Country of ref document: ES